Latest news about Vista Pharmaceuticals
Vista Pharmaceuticals
5.88
+0.27(+4.81%)
Company Performance:
View Company Insights1D+4.81%
1M-6.96%
6M-20.65%
1Y-39.32%
5Y-36.09%
More news about Vista Pharmaceuticals
13Feb 26
Vista Pharmaceuticals Reports Widened Q3 FY26 Loss at ₹231.94 Lakhs Amid Revenue Decline
Vista Pharmaceuticals Limited reported deteriorating financial performance for Q3 FY26 with net loss widening to ₹231.94 lakhs from ₹132.23 lakhs year-on-year, while revenue declined 5.35% to ₹241.82 lakhs. The company recognized ₹205.43 lakhs provision for Expected Credit Loss and has outstanding statutory liabilities of ₹95.48 lakhs, with results approved by the Board on February 13, 2026.
03Feb 26
Vista Pharmaceuticals Ltd Forms Strategic Joint Venture with Pleiades Therapeutics for Global Drug Development
Vista Pharmaceuticals Ltd has entered into a strategic joint venture partnership with Pleiades Therapeutics for collaborative development of generic and specialty pharmaceutical products targeting global markets. The partnership combines Pleiades Therapeutics' R&D expertise with Vista Pharmaceuticals' manufacturing capabilities and established marketing presence in the US and other key markets. The collaboration aims to enhance operational capabilities, expand market reach, and strengthen competitive positioning for both companies in the global pharmaceutical industry.
13Aug 25
Vista Pharmaceuticals Reports Widened Quarterly Loss, Reappoints Key Executives
Vista Pharmaceuticals Limited reported a net loss of Rs. 129.04 crore for Q1 FY2026, compared to Rs. 85.70 crore loss in Q1 FY2025. Revenue declined 15.4% to Rs. 151.88 crore. The company reappointed three key executives - Mr. Murali Meraga as Managing Director, Mr. Pavan Sathvik Gilaka and Mr. Dhananjaya Alli as Whole-time Directors for three-year terms. The 34th AGM is scheduled for September 30, 2025, via video conferencing. Book closure dates are set from September 24 to 30, 2025.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Zydus Life Science
Cipla
Laurus Labs
Aurobindo Pharma
Dr Reddys Laboratories
Lupin
Mankind Pharma
1,837.30
(-1.61%)
9,375.00
(+0.56%)
4,840.00
(-0.72%)
1,160.00
(+2.19%)
1,394.50
(+1.32%)
1,954.00
(+0.30%)
1,734.00
(+2.60%)
1,185.00
(+0.85%)
2,083.00
(-0.72%)
2,300.70
(+0.03%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
